SK281441B6 - Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu - Google Patents

Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu Download PDF

Info

Publication number
SK281441B6
SK281441B6 SK740-95A SK74095A SK281441B6 SK 281441 B6 SK281441 B6 SK 281441B6 SK 74095 A SK74095 A SK 74095A SK 281441 B6 SK281441 B6 SK 281441B6
Authority
SK
Slovakia
Prior art keywords
amino
tetrahydrobenzothiazole
propylamino
preparation
snd
Prior art date
Application number
SK740-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK74095A3 (en
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of SK74095A3 publication Critical patent/SK74095A3/sk
Publication of SK281441B6 publication Critical patent/SK281441B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK740-95A 1992-12-05 1993-12-02 Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu SK281441B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (2)

Publication Number Publication Date
SK74095A3 SK74095A3 (en) 1996-05-08
SK281441B6 true SK281441B6 (sk) 2001-03-12

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
SK740-95A SK281441B6 (sk) 1992-12-05 1993-12-02 Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu

Country Status (29)

Country Link
US (1) US6191153B1 (es)
EP (1) EP0675717B1 (es)
JP (1) JP3221880B2 (es)
KR (1) KR100311165B1 (es)
CN (1) CN1052400C (es)
AT (1) ATE183091T1 (es)
AU (1) AU674378B2 (es)
BG (1) BG62475B1 (es)
CA (1) CA2150131C (es)
CZ (1) CZ282679B6 (es)
DE (2) DE4241013A1 (es)
DK (1) DK0675717T3 (es)
ES (1) ES2136725T3 (es)
FI (1) FI952734A (es)
GR (1) GR3031521T3 (es)
HK (1) HK1019003A1 (es)
HU (1) HU221014B1 (es)
IL (1) IL107870A (es)
MX (1) MX9307644A (es)
NO (1) NO306930B1 (es)
NZ (1) NZ258876A (es)
PL (1) PL309282A1 (es)
RU (1) RU2157685C2 (es)
SG (1) SG49228A1 (es)
SK (1) SK281441B6 (es)
TW (1) TW362973B (es)
UA (1) UA35604C2 (es)
WO (1) WO1994013287A1 (es)
ZA (1) ZA939065B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
AU7887501A (en) * 2000-07-06 2002-01-21 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US8679533B2 (en) * 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
DE102004006808A1 (de) * 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
MX2007001765A (es) * 2004-08-13 2007-04-20 Boehringer Ingelheim Int Formulacion en comprimidos de liberacion extendida que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para su fabricacion y su uso.
UA95993C2 (ru) * 2004-08-13 2011-09-26 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
NZ561677A (en) * 2005-04-04 2011-02-25 Takeda Pharmaceutical (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide, and its use for treating depression and anxiety neurosis
CA2626249A1 (en) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Use of pramipexol for treating moderate to severe restless legs syndrome (rls)
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
IL269875B1 (en) * 2017-04-10 2024-02-01 Chase Therapeutics Corp NK1 antagonist combination and a method for the treatment of synucleinopathies
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
CA2150131C (en) 2004-09-21
NZ258876A (en) 1997-07-27
RU2157685C2 (ru) 2000-10-20
BG99700A (bg) 1996-04-30
FI952734A0 (fi) 1995-06-05
PL309282A1 (en) 1995-10-02
CZ282679B6 (cs) 1997-08-13
US6191153B1 (en) 2001-02-20
HU221014B1 (hu) 2002-07-29
HU9501623D0 (en) 1995-08-28
NO952207D0 (no) 1995-06-02
DE4241013A1 (de) 1994-06-09
NO952207L (no) 1995-06-02
SG49228A1 (en) 1998-05-18
CN1091635A (zh) 1994-09-07
ES2136725T3 (es) 1999-12-01
AU5715294A (en) 1994-07-04
ATE183091T1 (de) 1999-08-15
ZA939065B (en) 1994-08-04
DK0675717T3 (da) 2000-02-28
IL107870A (en) 1996-12-05
EP0675717B1 (de) 1999-08-11
CA2150131A1 (en) 1994-06-23
EP0675717A1 (de) 1995-10-11
HUT71798A (en) 1996-02-28
GR3031521T3 (en) 2000-01-31
HK1019003A1 (en) 2000-01-14
MX9307644A (es) 1994-06-30
NO306930B1 (no) 2000-01-17
KR950703953A (ko) 1995-11-17
FI952734A (fi) 1995-06-05
TW362973B (en) 1999-07-01
DE59309733D1 (de) 1999-09-16
IL107870A0 (en) 1994-04-12
SK74095A3 (en) 1996-05-08
UA35604C2 (uk) 2001-04-16
JPH08504201A (ja) 1996-05-07
JP3221880B2 (ja) 2001-10-22
CN1052400C (zh) 2000-05-17
CZ144095A3 (en) 1996-03-13
WO1994013287A1 (de) 1994-06-23
KR100311165B1 (ko) 2001-12-28
AU674378B2 (en) 1996-12-19
BG62475B1 (bg) 1999-12-30

Similar Documents

Publication Publication Date Title
SK281441B6 (sk) Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu
EP0317878B1 (de) Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen
MXPA00012957A (es) Composicion para dosis oral de liberacion extendida.
AU780011B2 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
SK284923B6 (sk) Zmes liečiv s antidepresívnym účinkom obsahujúca 2-amino-4,5,6,7- tetrahydro-6-propylaminobenzotiazol a sertralín a jej použitie
JPH01224316A (ja) 医薬製剤
NZ552998A (en) Anti-histaminic composition
EP0500851B1 (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
EP0205865B1 (de) Pharmazeutische Präparate mit antihypertensiver und kardioprotektiver Wirkung
SK284584B6 (sk) Tableta s riadeným uvoľňovaním
EP1655029B1 (en) Medicinal compositions
SK284264B6 (sk) Liečivo na liečenie syndrómu nepokojných nôh
AT393625B (de) Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten
JP6106359B2 (ja) ロキソプロフェンナトリウムとビタミンｂ１を含有する固形製剤
EP0508511B1 (de) Erzeugnisse, enthaltend Verapamil und Trandolapril
SK278918B6 (sk) Farmaceutický prostriedok proti vysokému krvnému t
JPS6110510A (ja) 免疫抑制作用を有する新規な医薬組成物
NZ509177A (en) Use of azabicyclic compounds for treating psychosis and neuropsychiatric symptoms in patients with alzheimerÆs disease
US3495005A (en) Compositions and methods for suppressing appetite with combinations of amphetamine and thioridazine
KR960008229B1 (ko) 캡토프릴 서방성 정제 및 그의 제조방법
JP2020203955A (ja) 医薬組成物、医薬組成物の製造方法、及び非晶質体の安定性を向上させる方法
EP0488041A2 (en) A pharmaceutical composition for cytomegalovirus infection
KR100701409B1 (ko) 호박산 수마트립탄을 함유하는 약제학적 조성물
US20040192706A1 (en) Method and compositions for treating anxiety
JPH03255026A (ja) 物質依存症に関する治療薬

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20131202